Literature DB >> 31280584

Characterization of HIV-1 Subtypes Among South Sudanese Patients.

Alessandra Lo Presti1, Stefania Farcomeni2, Lucia Fontanelli Sulekova3, Stefania Grieco3, Leonardo Sernicola2, Michela Baesso2, Maria T Maggiorella2, Silvia Angeletti4, Brian Foley5, Massimo Ciccozzi4, Gloria Taliani3, Alessandra Borsetti2.   

Abstract

There is scarce data on circulation of genetic subtypes of HIV-1 in South Sudan due to decades of civil war. In this study, phylogenetic analysis of 10 strains collected from HIV-1-infected South Sudanese patients was performed. Partial pol and env viral gene analysis classified sequences as subtype C (n = 4), subtype D (n = 4), and partially unclassifiable recombinants (n = 2), interspersed within the phylogenetic tree with those from other African countries. These results indicate an exchange of viral strains between South Sudan and both neighboring and distant territories. The movements of populations across Sudan's borders during the civil war have probably played an important role in circulation of subtypes not only in South Sudan but also in other African states.

Entities:  

Keywords:  Africa; HIV; South Sudan; diversity; dried blood spot

Year:  2019        PMID: 31280584     DOI: 10.1089/AID.2019.0133

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries.

Authors:  Mohamed A Daw; Mohamed O Ahmed
Journal:  World J Virol       Date:  2021-03-25

2.  Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia.

Authors:  Erdaw Tachbele; Samuel Kyobe; Fred Ashaba Katabazi; Edgar Kigozi; Savannah Mwesigwa; Moses Joloba; Alebachew Messele; Wondwossen Amogne; Mengistu Legesse; Rembert Pieper; Gobena Ameni
Journal:  Infect Drug Resist       Date:  2021-11-18       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.